These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3160969)

  • 1. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
    Barkhatova VP; Kandel' EI; Demina EG
    Neurosci Behav Physiol; 1985; 15(2):132-9. PubMed ID: 3160969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
    Barkhatova VP; Kandel' EI; Demina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 4. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 7. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C; Tharp BR; Cousin D
    J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
    [No Abstract]   [Full Text] [Related]  

  • 8. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of homovanillic acid determination in ventricular cerebrospinal fluid to assess brain dopamine metabolism in several extrapyramidal diseases].
    Barkhatova VP; Larskiĭ EG
    Lab Delo; 1979; (2):79-83. PubMed ID: 85750
    [No Abstract]   [Full Text] [Related]  

  • 10. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
    Davidson DL; Yates CM; Mawdsley C; Pullar IA; Wilson H
    J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in sleep disorders, epilepsy, degenerative chorea and acute cerebral vascular diseases].
    Livrea P
    Acta Neurol (Napoli); 1976; 31(5):580-600. PubMed ID: 138342
    [No Abstract]   [Full Text] [Related]  

  • 13. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
    Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
    Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
    [No Abstract]   [Full Text] [Related]  

  • 14. The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Erba G
    Neurology; 1972 Nov; 22(11):1151-9. PubMed ID: 4263829
    [No Abstract]   [Full Text] [Related]  

  • 15. Involuntary movements other than Parkinsonism: biochemical aspects.
    Curzon G
    Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indicators of brain biogenic amine metabolism in various extrapyramidal disorders].
    Barchatowa WP; Milewska D; Wehr H
    Neurol Neurochir Pol; 1981; 15(4):381-6. PubMed ID: 6173791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 18. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid.
    Chase TN; Gordon EK; Ng LK
    J Neurochem; 1973 Sep; 21(3):581-7. PubMed ID: 4270247
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)].
    Völler GW; Deze J
    Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogensis and medical treatment of extrapyramidal disease.
    Calne DB; Eisler T
    Med Clin North Am; 1979 Jul; 63(4):715-27. PubMed ID: 157413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.